{"id":5246,"date":"2010-12-06T15:29:58","date_gmt":"2010-12-06T20:29:58","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?p=5246"},"modified":"2011-07-19T17:44:41","modified_gmt":"2011-07-19T21:44:41","slug":"ticagrelor-gets-european-approval","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2010\/12\/06\/ticagrelor-gets-european-approval\/","title":{"rendered":"Ticagrelor Gets European Approval"},"content":{"rendered":"<p>Ticagrelor has received approval for marketing in Europe, according to <a href=\"http:\/\/cardiobrief.org\/2010\/12\/06\/7167\/#more-7167\">AstraZeneca<\/a>. The drug, which will go under the brand name of <em>Brilique<\/em> in Europe, will not be available in most European countries until the second half of 2011, the company said. A decision about the approval of ticagrelor in the U.S., where it will be called <em>Brilinta<\/em>, is expected later this month.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ticagrelor has received approval for marketing in Europe, according to AstraZeneca. The drug, which will go under the brand name of Brilique in Europe, will not be available in most European countries until the second half of 2011, the company said. A decision about the approval of ticagrelor in the U.S., where it will be [&hellip;]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[495,1,9],"tags":[463,240],"class_list":["post-5246","post","type-post","status-publish","format-standard","hentry","category-anticoagulation-2","category-general","category-interventional-cardiology","tag-antiplatelet-therapy","tag-ticagrelor"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/5246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=5246"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/5246\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=5246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=5246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=5246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}